Skip to main content
Monday, November 16, 2026Nov 16

Sanofi-Aventis Q4 profit up on swine flu vaccines

GREG KELLER

AP Business Writer

PARIS – Sanofi-Aventis reported a 10 percent increase in fourth quarter net profit Wednesday as strong sales of its swine flu vaccine drove full year earnings above expectations.

France’s largest drug maker said net profit rose to euro1.8 billion ($2.5 billion) in the three months ending Dec. 31 from euro1.63 billion a year earlier.

The company, whose Sanofi Pasteur division is the world’s biggest vaccines manufacturer, said the fourth quarter performance was lifted by a record rise – 64.6 percent – in revenue from its human vaccines business.